(ACRS) Aclaris Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Aclaris Therapeutics | (ACRS) share price targets
Complete technical analysis of Aclaris Therapeutics (ACRS) by charts plus indicators, forecast predictions and share price targets for Aclaris Therapeutics (ACRS)
Aclaris Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-02-08 View latest technical analysis
10 day averaged volume of Aclaris Therapeutics is 1266890
Date | Daily Closing Price | Open | High | Low | Volume |
08 Thu Feb 2024 | 1.18 | 1.08 | 1.20 | 1.06 | 0.884 times |
07 Wed Feb 2024 | 1.06 | 1.12 | 1.16 | 1.05 | 4.102 times |
06 Tue Feb 2024 | 1.14 | 1.15 | 1.19 | 1.12 | 0.713 times |
05 Mon Feb 2024 | 1.15 | 1.22 | 1.23 | 1.15 | 0.549 times |
02 Fri Feb 2024 | 1.21 | 1.18 | 1.24 | 1.17 | 0.544 times |
01 Thu Feb 2024 | 1.20 | 1.18 | 1.24 | 1.17 | 0.711 times |
31 Wed Jan 2024 | 1.16 | 1.21 | 1.23 | 1.16 | 0.484 times |
30 Tue Jan 2024 | 1.21 | 1.23 | 1.23 | 1.18 | 0.568 times |
29 Mon Jan 2024 | 1.22 | 1.25 | 1.27 | 1.20 | 1.16 times |
26 Fri Jan 2024 | 1.23 | 1.27 | 1.30 | 1.22 | 0.55 times |
My analysis of stock is bullish for shortterm, and stock might move up till 1.3 or till 1.4. Use a stoploss of 1.17 and if this stock hits its stoploss, then it can fall down till 1.07
Share price targets for Aclaris Therapeutics (ACRS)
Target Type | Value |
Downside Target | 0.59 |
Downside Target | 0.80 |
Downside Target | 0.86 |
Downside Target | 1.00 |
Downside Target | 1.04 |
Downside Target | 1.16 |
Upside Target | 1.23 |
Upside Target | 1.27 |
Upside Target | 1.32 |
Upside Target | 4.33 |
Upside Target | 5.71 |
Upside Target | 6.98 |
Intraday share price targets for Aclaris Therapeutics (ACRS)
Target Type | Value |
Downside Intraday Target | 1.08 |
Downside Intraday Target | 0.97 |
Upside Intraday Target | 1.26 |
Upside Intraday Target | 1.33 |
Downside Intraday Target | 1.15 |
Weekly technical analysis of Aclaris Therapeutics (ACRS)
Date | Weekly Closing Price | Open | High | Low | Volume |
08 Thu Feb 2024 | 1.18 | 1.22 | 1.23 | 1.05 | 1.802 times |
02 Fri Feb 2024 | 1.21 | 1.25 | 1.27 | 1.16 | 0.533 times |
26 Fri Jan 2024 | 1.23 | 1.19 | 1.32 | 1.16 | 0.682 times |
19 Fri Jan 2024 | 1.14 | 1.06 | 1.25 | 1.04 | 3.97 times |
12 Fri Jan 2024 | 0.92 | 0.95 | 1.00 | 0.86 | 0.122 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Aclaris Therapeutics (ACRS)
Date | Monthly Closing Price | Open | High | Low | Volume |
08 Thu Feb 2024 | 1.18 | 1.18 | 1.24 | 1.05 | 0.162 times |
31 Wed Jan 2024 | 1.16 | 1.10 | 1.32 | 0.86 | 0.929 times |
29 Fri Dec 2023 | 1.05 | 0.88 | 1.25 | 0.80 | 0.315 times |
30 Thu Nov 2023 | 0.87 | 5.00 | 5.71 | 0.59 | 8.384 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aclaris Therapeutics (ACRS)
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Aclaris Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Aclaris Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Aclaris Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aclaris Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.14 and Aclaris Therapeutics (ACRS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Aclaris Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Aclaris Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Aclaris Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aclaris Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.14 and Aclaris Therapeutics (ACRS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.